203
Views
1
CrossRef citations to date
0
Altmetric
ORIGINAL RESEARCH

Comparison of Clinical Outcomes of Endovascular Therapy and Hybrid Surgery in the Treatment of Trans-Atlantic Inter-Society Consensus II D Aortoiliac Occlusive Disease

, , , , , & show all
Pages 2149-2156 | Received 20 Mar 2023, Accepted 23 May 2023, Published online: 31 May 2023

References

  • Song P, Rudan D, Wang M, Chang X, Rudan I. National and subnational estimation of the prevalence of peripheral artery disease (PAD) in China: a systematic review and meta-analysis. J Glob Health. 2019;9(1):010601. doi:10.7189/jogh.09.010601
  • Upchurch Jr. GR, Dimick JB, Wainess RM, et al. Diffusion of new technology in health care: the case of aorto-iliac occlusive disease. Surgery. 2004;136(4):812–818. doi:10.1016/j.surg.2004.06.019
  • Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FGR; TASC II Working Group. Inter-society consensus for the management of peripheral arterial disease (TASC II). Eur J Vasc Endovasc Surg. 2007;33(1 Supplement):S1–S75.
  • Jongkind V, Akkersdijk GJM, Yeung KK, Wisselink W. A systematic review of endovascular treatment of extensive aortoiliac occlusive disease. J Vasc Surg. 2010;52(5):1376–1383. doi:10.1016/j.jvs.2010.04.080
  • Chiu KWH, Davies RSM, Nightingale PG, Bradbury AW, Adam DJ. Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg. 2010;39(4):460–471. doi:10.1016/j.ejvs.2009.12.014
  • Expert consensus writing group of lower extremity arterial disease Group, Vascular Surgery Committee, National Expert Committee on Cardiovascular Diseases. Vascular Surgery Committee, Chinese Medical Education Association. Association, Chinese expert consensus on diagnosis and treatment of aortoiliac occlusive disease. Chin Circ J. 2020;35(10):948–954.
  • Tewksbury R, Taumoepeau L, Cartmill A, Butcher A, Cohen T. Outcomes of covered expandable stents for the treatment of TASC D aorto-iliac occlusive lesions. Vascular. 2015;23(6):630–636. doi:10.1177/1708538114568479
  • Mayor J, Branco BC, Chung J, et al. Outcome comparison between open and endovascular management of TASC II D aortoiliac occlusive disease. Ann Vasc Surg. 2019;61:65–71.e3. doi:10.1016/j.avsg.2019.06.005
  • Yang M, Zhang B, Niu G, Yan Z, Tong X, Zou Y. Long-term results of endovascular reconstruction for aortoiliac occlusive disease. Quant Imaging Med Surg. 2021;11(4):1303–1312. doi:10.21037/qims-20-599
  • Rzucidlo EM, Powell RJ, Zwolak RM, et al. Early results of stent-grafting to treat diffuse aortoiliac occlusive disease. J Vasc Surg. 2003;37(6):1175–1180. doi:10.1016/S0741-5214(03)00326-4
  • Ray JJ, Eidelson SA, Karcutskie CA, et al. Hybrid revascularization combining iliofemoral endarterectomy and iliac stent grafting for transatlantic inter-society consensus C and D aortoiliac occlusive disease. Ann Vasc Surg. 2018;50:73–79. doi:10.1016/j.avsg.2017.11.061
  • Nyman U, Uher P, Lindh M, Lindblad B, Ivancev K. Primary stenting in infrarenal aortic occlusive disease. Cardiovasc Intervent Radiol. 2000;23(2):97–108. doi:10.1007/s002709910021
  • Björses K, Ivancev K, Riva L, Manjer J, Uher P, Resch T. Kissing stents in the aortic bifurcation – a valid reconstruction for aorto-iliac occlusive disease. Eur J Vasc Endovasc Surg. 2008;36(4):424–431. doi:10.1016/j.ejvs.2008.06.027
  • Kashyap VS, Pavkov ML, Bena JF, et al. The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction. J Vasc Surg. 2008;48(6):1451–1457.e3. doi:10.1016/j.jvs.2008.07.004
  • Ichihashi S, Higashiura W, Itoh H, Sakaguchi S, Nishimine K, Kichikawa K. Long-term outcomes for systematic primary stent placement in complex iliac artery occlusive disease classified according to Trans-Atlantic Inter-Society Consensus (TASC)-II. J Vasc Surg. 2011;53(4):992–999. doi:10.1016/j.jvs.2010.10.069
  • Taeymans K, Groot Jebbink E, Holewijn S, et al. Three-year outcome of the covered endovascular reconstruction of the aortic bifurcation technique for aortoiliac occlusive disease. J Vasc Surg. 2018;67(5):1438–1447. doi:10.1016/j.jvs.2017.09.015
  • Shen C, Zhang Y, Qu C, Fang J, Liu X, Teng L. Outcomes of Total Aortoiliac Revascularization for TASC-II C&D lesion with kissing self-expanding covered stents. Ann Vasc Surg. 2020;68:434–441. doi:10.1016/j.avsg.2020.04.055
  • Park KB, Do YS, Kim DI, et al. The TransAtlantic InterSociety Consensus (TASC) classification system in iliac arterial stent placement: long-term patency and clinical limitations. J Vasc Interv Radiol. 2007;18(2):193–201. doi:10.1016/j.jvir.2006.12.726
  • Sixt S, Alawied AK, Rastan A, et al. Acute and long-term outcome of endovascular therapy for aortoiliac occlusive lesions stratified according to the TASC classification: a single-center experience. J Endovasc Ther. 2008;15(4):408–416. doi:10.1583/08-2359.1
  • Psacharopulo D, Ferrero E, Ferri M, et al. Increasing efficacy of endovascular recanalization with covered stent graft for TransAtlantic Inter-Society Consensus II D aortoiliac complex occlusion. J Vasc Surg. 2015;62(5):1219–1226. doi:10.1016/j.jvs.2015.06.218
  • Ahn S, Park KM, Kim YK, et al. Outcomes of endovascular treatment for TASC C and D aorto-iliac lesions. Asian J Surg. 2017;40(3):215–220. doi:10.1016/j.asjsur.2015.11.006
  • Bracale UM, Giribono AM, Spinelli D, et al. Long-term results of endovascular treatment of TASC C and D aortoiliac occlusive disease with expanded polytetrafluoroethylene stent graft. Ann Vasc Surg. 2019;56:254–260. doi:10.1016/j.avsg.2018.07.060
  • Salem M, Hosny MS, Francia F, et al. Management of extensive aorto-iliac disease: a systematic review and meta-analysis of 9319 patients. Cardiovasc Intervent Radiol. 2021;44(10):1518–1535. doi:10.1007/s00270-021-02785-6
  • Rocha-Neves J, Ferreira A, Sousa J, et al. Endovascular approach versus aortobifemoral bypass grafting: outcomes in extensive aortoiliac occlusive disease. Vasc Endovascular Surg. 2020;54(2):102–110.